Sympathetic Neural Adaptation to Hypocaloric Diet With or Without Exercise Training in Obese Metabolic Syndrome Subjects

Nora E. Straznicky(Baker Heart and Diabetes Institute), Gavin Lambert(Swinburne University of Technology), Élisabeth Lambert(Swinburne University of Technology), Mariee McGrane(Baker Heart and Diabetes Institute), Eldho Paul(Monash Health), Markus P. Schlaich(The University of Western Australia), Paul J. Nestel(Baker Heart and Diabetes Institute), Reena Chopra(Google (United States)), Justin A. Mariani(Baker Heart and Diabetes Institute), Kazuko Masuo(Baker Heart and Diabetes Institute), Florentia Socratous(Baker Heart and Diabetes Institute), Barbora de Courten(Monash Health), Carolina I. Sari(Baker Heart and Diabetes Institute), Nina Eikelis(Baker Heart and Diabetes Institute), Tye Dawood(Baker Heart and Diabetes Institute), Murray Esler(Baker Heart and Diabetes Institute)
Diabetes
October 15, 2009
10.2337/db09-0934
Cited by 118

Related Papers

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
|The Lancet|2010|2.2k
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
|The Lancet|2009|2.1k
Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity.
|Circulation|1986|1k
Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins
|JAMA|2012|800
Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions
|Physiological Reviews|1990|792